0.000USD0.000盤前交易 08/03, 09:30 (美東)
關鍵數據
4.170今開
4.210最高
2.99M成交量
19.87本益比TTM
36.22本益比動
--股利TTM
2.01%換手率
4.270昨收
3.973最低
7.76M成交額
14.50本益比靜
2.53市淨率
0.00%股息率 TTM
10.60%ROA
7.99052週最高
1.17量比
42.42M淨利潤
148.93M總股本
0.2078每股盈餘TTM
1.47Beta
13.77%ROE
3.02552週最低
5.56%振幅
68.50%毛利率
601.99M總市值
2.00回報/風險
2.46%風險率
操作建議
MiMedx Group Inc當前公司基本面數據相對非常健康,增長潛力較大。當前估值合理,在生物技術與醫療研究行業排名77/385位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為6.60。中期看,股價處於上升通道。近一個月,市場表現一般,但基本面評分較高。目前股價在壓力位和支撐位之間,可以做區間波段操作。
壓力支撐

由於公司未披露,未能獲取相關數據
MiMedx Group Inc新聞
即將為您帶來更多新聞,敬請期待。 。 。
收益預測
Ionis Pharmaceuticals Inc
IONS
27
Kymera Therapeutics Inc
KYMR
24
技術指標
財務指標
每股收益

由於公司未披露,未能獲取相關數據
營業總收入

由於公司未披露,未能獲取相關數據
MiMedx Group Inc簡介
MiMedx Group, Inc. is a placental biologics company focused on providing a portfolio of products for applications in the wound care, burn, and surgical sectors of healthcare. Its product portfolio categories include Wound Care and Surgical. The Wound Care products include EPIFIX and EPIEFFECT, which are marketed for external use, such as in advanced wound care applications. Its EPICORD, EPICORD Expandable and EPIEFFECT product lines also offer an alternative treatment option to address larger, deeper wounds. Its Surgical and Other product offering includes AMNIOFIX and AMNIOEFFECT, which are used in a variety of applications and surgical settings, including lower extremity repair, plastic surgery, vascular surgery and multiple orthopedic repairs and reconstructions. It also offers HELIOGEN, an advanced bovine collagen matrix containing type I and type III collagen that is intended for the management of moderately to heavily exudating wounds and to control minor bleeding.
公司代碼MDXG
公司MiMedx Group Inc
CEOCapper (Joseph H)
網址https://mimedx.com/
公司股東
常見問題
MiMedx Group Inc(MDXG)的當前股價是多少?
MiMedx Group Inc(MDXG)的當前股價是 4.13。
MiMedx Group Inc 的股票代碼是什麼?
MiMedx Group Inc的股票代碼是MDXG。
MiMedx Group Inc股票的52週最高點是多少?
MiMedx Group Inc股票的52週最高點是7.99。
MiMedx Group Inc股票的52週最低點是多少?
MiMedx Group Inc股票的52週最低點是3.02。
MiMedx Group Inc的市值是601.99M。
現在MiMedx Group Inc(MDXG)的股票是買入、持有還是賣出?
根據分析師評級,MiMedx Group Inc(MDXG)的總體評級為買入,目標價格為6.60。
MiMedx Group Inc(MDXG)股票的每股收益(EPS TTM)是多少
MiMedx Group Inc(MDXG)股票的每股收益(EPS TTM)是0.33。